from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1345/mbtM

LFCtreatmentdescriptionclass of inhibitor

0.485

Amikacinug/mL Amikacintranslation

-0.788

Cap5-10ug/mL Capreomycintranslation

-1.315

Rox10-50 ug/mL Roxithromycintranslation

-0.127

SM2-5 ug/mL Streptomycintranslation

-1.382

Tet5-10 ug/mL Tetracyclinetranslation

2.005

Rif0.2-5ug/mL Rifampicintranscription

1.201

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.285

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.813

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.080

CPZ10-50 ug/mL Chlorpromazinerespiration

1.313

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.532

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.318

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.394

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.722

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.723

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.704

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.448

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.008

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.455

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.662

KCN5-20 ug/mL Potassium cyaniderespiration

0.001

NaN30.2-2 mM Sodium aziderespiration

-1.512

Nigericin50 uM Nigericinrespiration

0.342

TRC10-150 ug/mL Triclosanrespiration

0.866

TRZ10-25 ug/mL Thioridazinerespiration

-1.080

Valinomycin0.5-10 uM Valinomycinrespiration

-1.348

ZnSO42 mM ZnSO4respiration

-0.437

menadione6-10 ug/mL Menadionerespiration

1.051

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.271

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.989

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.469

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.163

NRP_1Non-replicating persistence stage 1dosRassociated

0.437

Amp0.2mg/mL AmpicillincellWall

-0.617

Cephalexin20-100 ug/mL CephalexincellWall

-0.618

Cerulenin0.32-5 ug/mL CerulenincellWall

1.053

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.561

EMB10-20 ug/mL EthambutolcellWall

0.023

Eta12-40 ug/mL EthionamidecellWall

0.047

INH0.2-0.4 ug/mL IsoniazidcellWall

0.476

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.871

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.538

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.014

BZA0.12 mg/mL BenzamidearomaticAmides

0.162

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.294

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.035

H2O24 mM hydrogen peroxideDNAdamaging

0.484

Levo10 ug/mL LevofloxacinDNAdamaging

-0.207

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.514

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.487

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.274

UVUV-irradiationDNAdamaging

0.538

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.221

Antimycin12.5-50 ug/mL Antimycin A?

-0.456

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.311

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.251

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.802

PA8240.2-2 ug/mL PA-824?

-0.586

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.341

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.361

Verapamil50 uM Verapamil?

0.021

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.531

methoxatin10-20 ug/mL Methoxatin?